EPAS1 and pancreatic ductal adenocarcinoma: Cancer-associated fibroblast (CAF)-specific deletion of HIF-2α, but not HIF-1α, delayed pancreatic ductal adenocarcinoma (PDAC) tumor progression and growth, and improved survival of mice, suggesting a tumor promoting role for HIF-2α in fibroblasts [83].